FDA Inspection 1234038 - Janaki (NMI) Nadarajah DPM - March 07, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Janaki (NMI) Nadarajah DPM, with an inspection on March 7, 2024, issued by the Atlanta District Office, covering human drugs.

Company: Janaki (NMI) Nadarajah DPM
Inspection Date: March 7, 2024
Product Type: Human Drugs
Office: Atlanta District Office

Open in Dashboard

ID · 304a10e6-2229-484a-95c5-59c1dae760b0

Violation Codes3

21 CFR 312.6021 CFR 312.62(a)21 CFR 312.62(b)

Full citation text and observation details available on the Dashboard.